See also this year's filing and all EDGAR filings for this company.
PDF Report 0001388320_2024_Actinium_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001388320, Actinium Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 78,263,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 550,000 |
| 3 | remainder_Assets | 2,632,000 |
| 4 | LiabilitiesCurrent | 8,494,000 |
| 5 | LiabilitiesNoncurrent | 1,553,000 |
| 6 | remainder_Liabilities | 35,019,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,587,461 |
| 9 | ResearchAndDevelopmentExpense | 60,908,042 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 96,697 |
| 12 | remainder_NetIncome | 3,049,472 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,445,000 |
| 1 | Liabilities | 45,066,000 |
| 2 | Expenses | 74,495,503 |
| 3 | Revenues | 96,697 |
| 4 | StockholdersEquity | 36,379,000 |
| 5 | NetIncome | -71,349,334 |
| 6 | ComprehensiveNetIncome | -71,349,334 |
| 7 | BaseVar | 102,076,336 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.126 |
| 9 | EconomicCapitalRatio | 1.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
